Premarket Movers | RAPT Therapeutics Rockets 63%; AppLovin Plunges 11%; Crypto Shares Sink With SBET, Cipher Mining down about 8%

RAPT Therapeutics shares surged over 63% in premarket trading. Britain's GSK will buy RAPT Therapeutics for $2.2 billion, adding global rights to the U.S. firm's experimental food allergy drug ozureprubart to its respiratory and immunology portfolio, the drugmakers said on Tuesday.

AppLovin shares slumped 11% in premarket trading. AppLovin Corp. captured the attention of retail investors on Monday after a short-seller report accused one of its major shareholders of money laundering, with recent stock price declines and analyst remarks further dampening investor sentiment.

Crypto shares slid in premarket trading as Bitcoin dropped below $91,000 and Ethereum dropped to $3,130. SharpLink Gaming, Cipher Mining down about 8%; BitMine, CleanSpark down around 7%; MARA down 6%.